TrialClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19: final results.

Florence Ader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.